CombiFlow: Flow cytometry-based identification and characterization of genetically and functionally distinct AML subclones

Many cancers, including leukemias, are dynamic oligoclonal diseases. Tools to identify and prospectively isolate genetically distinct clones for functional studies are needed. We describe our CombiFlow protocol, which is a combinatorial flow cytometry-based approach to identify and isolate such dist...

Descripción completa

Detalles Bibliográficos
Autores principales: Houtsma, Roos, Hogeling, Shanna M., Schuringa, Jan Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482290/
https://www.ncbi.nlm.nih.gov/pubmed/34622222
http://dx.doi.org/10.1016/j.xpro.2021.100864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482290/
https://www.ncbi.nlm.nih.gov/pubmed/34622222
http://dx.doi.org/10.1016/j.xpro.2021.100864

Ejemplares similares